Superstring Capital Management LP

SEC CIK: 0001931118
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by Superstring Capital Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overview All 13F holders of AVTX Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2025

Holdings of AVTX by Superstring Capital Management LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−153,313−100.0%	Sold out	Holders
Q4 2025	153,313	$2.78M	1.5%	−34,767−18.5%	Reduced	Holders
Q3 2025	188,080	$2.39M	2.4%	+188,080	New	Holders